<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(1)</volume><submitter>Shao T</submitter><journal>Signal transduction and targeted therapy</journal><pagination>132</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7391632</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Construction of paclitaxel-based antibody-drug conjugates with a PEGylated linker to achieve superior therapeutic index.</pubmed_title><pmcid>PMC7391632</pmcid><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Guo M</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Ju D</pubmed_authors><pubmed_authors>Shao T</pubmed_authors><pubmed_authors>Chen YL</pubmed_authors><pubmed_authors>Zhu T</pubmed_authors><pubmed_authors>Chen T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Construction of paclitaxel-based antibody-drug conjugates with a PEGylated linker to achieve superior therapeutic index.</name><description/><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2024-12-03T22:15:41.343Z</modification><creation>2024-12-03T22:15:41.343Z</creation></dates><accession>S-EPMC7391632</accession><cross_references><pubmed>32728048</pubmed><doi>10.1038/s41392-020-00247-y</doi></cross_references></HashMap>